Steven P. Ball - Concepedia

Concepedia

Author

Steven P. Ball

University of Massachusetts Chan Medical School

Also Known As

S Ball, S P Ball, S. Ball, S. P. Ball, S.P. BALL, Steven Ball, Steven P Ball, Steven P. Ball

38

Publications

1.1K

Citations

20

H-Index

25

Concepts

All Affiliations

University of Massachusetts Chan Medical School University of Vermont Medical Center Massachusetts Academy of Math and Science at WPI UMass Memorial Medical Center Brigham and Women's Hospital

SP

About

Steven P. Ball is an author at University of Massachusetts Chan Medical School specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	948
2	Emergency Medicine	10	10	597
3	Public Health	4	4	140
4	Biomedical Engineering	2	2	50
5	Epidemiology	1	1	15

Steven P. Ball

×

22

Publications

1.1K

Citations

19

H-Index

	Year	Citations
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Richard C. Becker, Frederick A. Spencer, Michael Gibson, American Heart Journal ThrombosisRenal FunctionCardiovascular DiseaseMedicineEnoxaparin Administration	2002	165
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists Richard C. Becker, Judith S. Hochman, Christopher P. Cannon, Journal of the American College of Cardiology ThrombosisFatal Cardiac RuptureCardiovascular DiseaseThrombolytic AgentsCoagulopathy	1999	149
Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice Richard C. Becker, Maureen Burns, Joel M. Gore, American Heart Journal ThrombosisCardiovascular DiseaseCoronary UnitNationwide PerspectivePatient Safety	1998	86
Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction Joel M. Gore, Robert Roberts, Steven P. Ball, The American Journal of Cardiology ThrombosisCardiovascular DiseaseThrombolytic TherapyCardiologyAcute Myocardial Infarction	1987	84
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease Richard C. Becker, Steven P. Ball, Paul Eisenberg, American Heart Journal ThrombosisVenous ThrombosisActive Thromboembolic DiseaseCardiovascular DiseasePoint-of-care Coagulation Monitoring	1999	71
GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention M.I. Furman, Lori A. Krueger, Matthew D. Linden, Journal of Thrombosis and Haemostasis ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseMedicinePharmacotherapy	2005	54
Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study. Jack Ansell, Valerie Klassen, Robert Lew, PubMed Cardiac AnaesthesiaBlood LossPharmacotherapyFactor Viii ActivityThrombosis	1992	52
Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? Jack Ansell, Valerie Klassen, Robert Lew, Journal of Thoracic and Cardiovascular Surgery	1992	52
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes Richard C. Becker, Frederick A. Spencer, Youfu Li, Journal of the American College of Cardiology Thrombin GenerationThrombosisVenous ThrombosisCardiovascular DiseaseBlood Platelet	1999	49
Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction A.Christian Held, Joel M. Gore, John A Paraskos, The American Journal of Cardiology ThrombosisVenous ThrombosisCardiovascular DiseaseThrombolytic TherapyCardiology	1988	47

Page 1